152 related articles for article (PubMed ID: 24858098)
1. Synthesis, cytotoxicity and mechanistic evaluation of 4-oxoquinoline-3-carboxamide derivatives: finding new potential anticancer drugs.
Forezi Lda S; Tolentino NM; de Souza AM; Castro HC; Montenegro RC; Dantas RF; Oliveira ME; Silva FP; Barreto LH; Burbano RM; Abrahim-Vieira B; de Oliveira R; Ferreira VF; Cunha AC; Boechat Fda C; de Souza MC
Molecules; 2014 May; 19(5):6651-70. PubMed ID: 24858098
[TBL] [Abstract][Full Text] [Related]
2. Green Synthesis of Oxoquinoline-1(2H)-Carboxamide as Antiproliferative and Antioxidant Agents: An Experimental and In-Silico Approach to High Altitude Related Disorders.
Ali A; Ali A; Warsi MH; Rahman MA; Ahsan MJ; Azam F
Molecules; 2022 Jan; 27(1):. PubMed ID: 35011539
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, in silico and in vitro studies of new 1,4-dihydropiridine derivatives for antitumor and P-glycoprotein inhibitory activity.
Mollazadeh S; Sahebkar A; Kalalinia F; Behravan J; Hadizadeh F
Bioorg Chem; 2019 Oct; 91():103156. PubMed ID: 31416030
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and docking studies of novel 1,2-dihydro-4-hydroxy-2-oxoquinoline-3-carboxamide derivatives as a potential anti-proliferative agents.
Banu S; Bollu R; Bantu R; Nagarapu L; Polepalli S; Jain N; Vangala R; Manga V
Eur J Med Chem; 2017 Jan; 125():400-410. PubMed ID: 27688193
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, molecular modeling, and biological evaluation of novel chiral thiosemicarbazone derivatives as potent anticancer agents.
Taşdemir D; Karaküçük-İyidoğan A; Ulaşli M; Taşkin-Tok T; Oruç-Emre EE; Bayram H
Chirality; 2015 Feb; 27(2):177-88. PubMed ID: 25399965
[TBL] [Abstract][Full Text] [Related]
6. N-Substituted piperazinyl quinolones as potential cytotoxic agents: structure-activity relationships study.
Foroumadi A; Emami S; Rajabalian S; Badinloo M; Mohammadhosseini N; Shafiee A
Biomed Pharmacother; 2009 Mar; 63(3):216-20. PubMed ID: 18328669
[TBL] [Abstract][Full Text] [Related]
7. An efficient one-pot approach for the regio- and diastereoselective synthesis of trans-dihydrofuran derivatives: cytotoxicity and DNA-binding studies.
Tangella Y; Manasa KL; Laxma Nayak V; Sathish M; Sridhar B; Alarifi A; Nagesh N; Kamal A
Org Biomol Chem; 2017 Aug; 15(32):6837-6853. PubMed ID: 28782777
[TBL] [Abstract][Full Text] [Related]
8. Novel brominated quinoline and pyrimidoquinoline derivatives as potential cytotoxic agents with synergistic effects of γ-radiation.
Ghorab MM; Ragab FA; Heiba HI; Nissan YM; Ghorab WM
Arch Pharm Res; 2012 Aug; 35(8):1335-46. PubMed ID: 22941476
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Anticancer Evaluation of Some Synthesized 2H-Quinolinone and Halogenated 2H-Quinolinone Derivatives as Therapeutic Agents.
El-Aziz RMA; Zaki I; El-Deen IM; Abd-Rahman MS; Mohammed FZ
Anticancer Agents Med Chem; 2020; 20(18):2304-2315. PubMed ID: 32781965
[TBL] [Abstract][Full Text] [Related]
10. Molecular modeling based synthesis and evaluation of in vitro anticancer activity of indolyl chalcones.
Gaur R; Yadav DK; Kumar S; Darokar MP; Khan F; Bhakuni RS
Curr Top Med Chem; 2015; 15(11):1003-12. PubMed ID: 25860176
[TBL] [Abstract][Full Text] [Related]
11. Unravelling the anticancer potency of 1,2,4-triazole-N-arylamide hybrids through inhibition of STAT3: synthesis and in silico mechanistic studies.
Turky A; Bayoumi AH; Sherbiny FF; El-Adl K; Abulkhair HS
Mol Divers; 2021 Feb; 25(1):403-420. PubMed ID: 32830299
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, molecular docking, anticancer evaluations, and in silico pharmacokinetic studies of novel 5-[(4-chloro/2,4-dichloro)benzylidene]thiazolidine-2,4-dione derivatives as VEGFR-2 inhibitors.
El-Adl K; El-Helby AA; Sakr H; Ayyad RR; Mahdy HA; Nasser M; Abulkhair HS; El-Hddad SSA
Arch Pharm (Weinheim); 2021 Feb; 354(2):e2000279. PubMed ID: 33073374
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, Molecular Docking and Biological Evaluation of Quinolone Derivatives as Novel Anticancer Agents.
Li J; Zheng TC; Jin Y; Xu JG; Yu JG; Lv YW
Chem Pharm Bull (Tokyo); 2018 Jan; 66(1):55-60. PubMed ID: 29118308
[TBL] [Abstract][Full Text] [Related]
14. Molecular Docking, G-QSAR Studies, Synthesis and Anticancer Screening of Some New 2-Phenazinamines as Bcr-Abl Tyrosine Kinase Inhibitors.
Kale MA; Sonwane GM
Curr Drug Discov Technol; 2020; 17(2):213-224. PubMed ID: 30210004
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Cytotoxic Analysis of Novel Myrtenyl Grafted Pseudo-Peptides Revealed Potential Candidates for Anticancer Therapy.
Concepción O; Belmar J; F de la Torre A; M Muñiz F; Pertino MW; Alarcón B; Ormazabal V; Nova-Lamperti E; Zúñiga FA; Jiménez CA
Molecules; 2020 Apr; 25(8):. PubMed ID: 32326138
[TBL] [Abstract][Full Text] [Related]
16. Microwave-Assisted Facile Synthesis, Anticancer Evaluation and Docking Study of N-((5-(Substituted methylene amino)-1,3,4-thiadiazol-2-yl)methyl) Benzamide Derivatives.
Tiwari SV; Siddiqui S; Seijas JA; Vazquez-Tato MP; Sarkate AP; Lokwani DK; Nikalje APG
Molecules; 2017 Jun; 22(6):. PubMed ID: 28617341
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis, Anticancer Evaluation and Docking Studies of Novel Heterocyclic Derivatives Obtained via Reactions Involving Curcumin.
Borik RM; Fawzy NM; Abu-Bakr SM; Aly MS
Molecules; 2018 Jun; 23(6):. PubMed ID: 29890691
[TBL] [Abstract][Full Text] [Related]
18. A Novel Naphthotriazolyl-4-oxoquinoline Derivative that Selectively Controls Breast Cancer Cells Survival Through the Induction of Apoptosis.
Branco JR; Oliveira VG; Esteves AM; Chipoline IC; Lima MFO; Boechat FCS; da Silva FC; Ferreira VF; Sola-Penna M; de Souza MCBV; Zancan P
Curr Top Med Chem; 2018; 18(17):1465-1474. PubMed ID: 30129412
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and evaluation of new 2-oxoquinoline arylaminothiazole derivatives as potential anticancer agents.
Fang Y; Wu Z; Xiao M; Wei L; Li K; Tang Y; Ye J; Xiang J; Hu A
Bioorg Chem; 2021 Jan; 106():104469. PubMed ID: 33239239
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, molecular docking and anti-proliferative evaluations of [1,2,4]triazolo[4,3-a]quinoxaline derivatives as DNA intercalators and Topoisomerase II inhibitors.
El-Adl K; El-Helby AA; Sakr H; Elwan A
Bioorg Chem; 2020 Dec; 105():104399. PubMed ID: 33113414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
